Culture

Rare genetic syndrome identified, caused by mutations in gene SATB1

Advances in DNA sequencing have uncovered a rare syndrome which is caused by variations in the gene SATB1.

The study, co-authored by academics from Oxford Brookes University (UK), University of Lausanne (Switzerland), Radboud University (The Netherlands), University of Oxford (UK), University of Manchester (UK) and led by Max Planck Institute for Psycholinguistics (The Netherlands), discovered three classes of mutations within the gene SATB1, resulting in three variations of a neurodevelopmental disorder with varying symptoms ranging from epilepsy to muscle tone abnormalities.

Recognition of disorder will increase understanding and diagnosis

An international team of geneticists and clinicians from 12 countries identified 42 patients with mutations in the gene SATB1 who were all displaying a range of similar symptoms, albeit of varying severity.

Variations, or mutations, of SATB1 were found to have different effects in the cell. For example, some variations led to increased activity of the protein which causes a more severe type of disorder, while other variations cause loss of function of the gene and lead to less severe difficulties.

The SATB1-syndrome is characterised by neurodevelopmental delay, intellectual disability, muscle tone abnormalities, epilepsy, behavioural problems, facial dysmorphism and dental abnormalities.

Dr Dianne Newbury, Senior Lecturer in Medical Genetics and Genomics at Oxford Brookes University said: "Previously, just one or two cases of patients with SATB1 variations had been described but it was not recognised as a specific syndrome. Patients displaying these characteristics and their families, will have known that they had an undefined neurological condition, but they wouldn't have known any specific detail about the condition, or why they had it.

"We hope that the recognition of this new disorder, and the information about the molecular pathways contributing to it, will help the families and individuals affected understand more about the condition and achieve a diagnosis they would not have had previously."

Three classes of mutation have different effects in the cell

The mutations found in the genome of the patients were found to belong to three different classes. The first mutation class, identified in eight patients, caused a loss of function of the SATB1 gene and halved the production of the encoded protein. This leads to a less severe syndrome characterised by diminished cognitive function, visual problems and facial dysmorphism.

The second class contains four mutations, which encode shorter proteins that are less efficient as they are not positioned correctly in the cell. This second mutation shows as an intermediary syndrome, characterised as more severe than the first, but less severe than the third.

The third class of variation encompasses the mutations found in the last thirty patients. These modify the encoded protein, making it more active. This altered protein is 'sticky' and binds better to DNA, diminishing the expression of genes it regulates and causing a more severe type of disorder, characterised by severe intellectual disability, epilepsy, a motor speech disorder (dysarthria) and specific facial features.

Understanding mutations is key to discovering the origin of genetic diseases

Dr Alexandre Reymond, Director of the Center for Integrative Genomics at the University of Lausanne in Switzerland said: "These results demonstrate that each mutation is different and that is essential to understand their mode of action in order to explain the origin of genetic diseases.

"We must go beyond sequencing, which is only a first step."

Credit: 
Oxford Brookes University

Neural network has learned to identify tree species

image: Hierarchical model structure

Image: 
Svetlana Illarionova et al., IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing.

Skoltech scientists have developed an algorithm that can identify various tree species in satellite images. Their research was published in the IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing.

Identifying tree species is essential for efficient forest management and monitoring. Satellite imagery is an easier and cheaper way to deal with this task than other approaches that require ground observations of vast and remote areas.

Researchers from the Skoltech Center for Computational and Data-Intensive Science and Engineering (CDISE) and Skoltech Space Center used a neural network to automate dominant tree species' identification in high and medium resolution images. A hierarchical classification model and additional data, such as vegetation height, helped further enhance the predictions' quality while improving the algorithm's stability to facilitate its practical application.

"Commercial forest taxation providers and their end-users, including timber procurers and processors, as well as the forest industry entities can use the new technology for quantitative and qualitative assessment of wood resources in leased areas. Also, our solution enables quick evaluations of underdeveloped forest areas in terms of investment appeal," explains Svetlana Illarionova, the first author of the paper and a Skoltech PhD student.

There are plans to integrate the developed algorithms in the Geoalert platform to automate the production of forest engineering materials marketed via Parma-GIS.

Credit: 
Skolkovo Institute of Science and Technology (Skoltech)

Frequent cannabis use by young people linked to decline in IQ

image: Professor Mary Cannon, Professor of Psychiatric Epidemiology and Youth Mental Health, RCSI University of Medicine and Health Sciences

Image: 
Ray Lohan/ RCSI

Thursday, 28 January 2021: A study has found that adolescents who frequently use cannabis may experience a decline in Intelligence Quotient (IQ) over time. The findings of the research provide further insight into the harmful neurological and cognitive effects of frequent cannabis use on young people.

The paper, led by researchers at RCSI University of Medicine and Health Sciences, is published in Psychological Medicine.

The results revealed that there were declines of approximately 2 IQ points over time in those who use cannabis frequently compared to those who didn't use cannabis. Further analysis suggested that this decline in IQ points was primarily related to reduction in verbal IQ.

The research involved systematic review and statistical analysis on seven longitudinal studies involving 808 young people who used cannabis at least weekly for a minimum of 6 months and 5308 young people who did not use cannabis. In order to be included in the analysis each study had to have a baseline IQ score prior to starting cannabis use and another IQ score at follow-up. The young people were followed up until age 18 on average although one study followed the young people until age 38.

"Previous research tells us that young people who use cannabis frequently have worse outcomes in life than their peers and are at increased risk for serious mental illnesses like schizophrenia. Loss of IQ points early in life could have significant effects on performance in school and college and later employment prospects," commented senior author on the paper Professor Mary Cannon, Professor of Psychiatric Epidemiology and Youth Mental Health, RCSI.

"Cannabis use during youth is of great concern as the developing brain may be particularly susceptible to harm during this period. The findings of this study help us to further understand this important public health issue," said Dr Emmet Power, Clinical Research Fellow at RCSI and first author on the study.

The study was carried out by researchers from the Department of Psychiatry, RCSI and Beaumont Hospital, Dublin (Prof Mary Cannon, Dr Emmet Power, Sophie Sabherwal, Dr Colm Healy, Dr Aisling O'Neill and Professor David Cotter).

The research was funded by a YouLead Collaborative Doctoral Award from the Health Research Board (Ireland) and a European Research Council Consolidator Award.

Credit: 
RCSI

Crowdfunding? Check weather forecast first!

Investors' moods are affected by gloomy weather. New research from Copenhagen Business School recommends entrepreneurs looking for finance should be aware of the weather forecast at the time they want to launch their crowdfunding campaigns.

The researchers wanted to explore whether weather-induced moods can explain crowdfunders' contributions and focused on the role of investors' moods and emotions including day-to-day decisions on the crowdfunding platform Companisto.

"Financial investment plays a vital role in the success of an entrepreneurial venture and our research shows that on cloudy days, funders invest between 10-15% less money in risky equity crowdfunding campaigns," says Assistant Professor Ali Mohammadi from Department of Strategy and Innovation, Copenhagen Business School.

"We also show there is no differences between male and female investors and find that novice investors react more to the gloomy weather," adds Mohammadi.

The research is published in the Journal of Corporate Finance with co-author Kourosh Shafi, Assistant Professor of Entrepreneurship, California State University East Bay, Hayward, CA, USA.

Mood fluctuations

This research complements existing evidence on the link between weather as a mood stimulus and outcomes in various financial markets but what is different here is the focus on equity crowdfunding.

The quantitative research data came from the German company Companisto, one of the largest European equity crowdfunding platforms and consisted of examining 102 campaigns which received 67,982 pledges. This allowed the researchers to observe the city of where the investor lived and allowed them to link the weather data to the investor and the exact day of each investment.

"The weather measure is simply cloud coverage, which varies from no cloud at all (0) to completely cloudy (1). Hence, we can see weather fluctuation for the same campaign during the fundraising period. This setting allows us to isolate the effect of weather from effect of entrepreneur and investor characteristics. What is interesting about mood is that it is not directly related to economic value or return of an investment," adds Assistant Professor Mohammadi.

Maximise fundraising success

While entrepreneurs cannot fully predict the weather to strategically time the campaign launch to maximise fundraising success, there are a number of strategies the researchers recommend that could be considered to offset the adverse effects of cloudy days.

"These include targeting more experienced investors and engaging in campaigns at a later stage of venture development if possible. On cloudy days, entrepreneurs can also increase their marketing activities in ways that reduce the negative effect of weather," concludes Mohammadi.

Credit: 
Copenhagen Business School

New gene variant linked to stroke

Researchers at Lund University in Sweden believe they have identified a gene variant that can cause cerebral small vessel disease and stroke. The study is published in Neurology Genetics.

"The patients we have studied are from the same extended family, and several of them have been diagnosed with cerebral small vessel disease and suffered strokes. After tissue examination and using genetic sequencing methods, we found that they were carriers of a new gene variant that could be connected to their diagnoses," says Andreea Ilinca, researcher at Lund University and neurologist at Skåne University Hospital.

Stroke is either caused by a blood clot that leads to a lack of oxygen in the brain, or a hemorrhage in the brain. High blood pressure, high cholesterol levels, diabetes, atrial fibrillation and lifestyle factors such as smoking are known risk factors for stroke. However, an increasing amount of research is indicating that genetic factors also play a major role.

Therefore, the Lund researchers have studied an extended family, the majority of whom live in southern Sweden, where eight out of 15 people developed cerebral small vessel disease. The disease is characterized by ischemic stroke (cerebral infarction caused by blood clots) and cerebral hemorrhage, as well as mild cognitive impairment, autonomic nervous system dysfunctions and coordination difficulties.

When examining tissue from those that had experienced symptoms, the researchers could see microscopic changes in the blood vessels of the brain and in small skin vessels.

Using modern genetic analysis methods, they were also able to establish that they had found a new variant in the MAP3K6 gene, that they believe may be related to the disease. MAP3K6 is a gene that, among other things, affects the function of a protein that helps the brain's blood vessels to react correctly to damage, such as a low oxygen supply to the brain.

"By identifying genetic variants that are associated with disease in the vessels of the brain and early stroke, we can better understand what could prevent these harmful processes. Future studies that can give us more knowledge about the molecular disease mechanism can lead to new treatments", concludes Andreea Ilinca.

Credit: 
Lund University

New AI-severity score COVID-19 integrating CT images published to Nature Communications

Paris, France, January 27th 2021 -- COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections. Owkin, a French-American startup pioneering AI and Federated Learning in medical research, has been focusing it's COVID-19 research efforts on aspects of the pandemic that still require much public health attention, despite the arrival of an effective vaccine.

Efforts to support frontline health systems as they devote their resources to the influx of COVID-19 related hospitalizations, have resulted in the AI-Severity Score, published in Nature Communications this week . This machine learning model, trained on multimodal data sets that include CT scans of the lungs (a routine procedure upon admission), is plug and play and able to predict the severity of a patient's disease prognosis with a performance that surpasses all other currently published score benchmarks. Use of these scores supports hospital resource management and planning, a sometimes overlooked function that, when managed well, saves lives. This research was made possible through a consortium, called ScanCovIA, made up of Institut Gustave Roussy, Kremlin-Bicêtre APHP, Owkin, and Digital Vision Center of CentraleSupélec and INRIA.

Additionally, Owkin has been developing other machine learning models to discover more coronavirus epitopes that are most likely to be effective in future vaccines As the virus continues to mutate, we don't yet know how long the current vaccines will remain efficacious or if, like the flu, they will require annual or semi annual development. Furthermore, it may be possible to develop vaccines for genes within the virus's DNA that are more stable, and less likely to mutate. Epitope prediction can speed vaccine development by narrowing the field of epitopes to test in the lab, and it can diversify our defenses against the virus's future mutations. Furthermore, these models can be deployed outside vaccine research; they can also be used in oncology research. The ultimate aim of machine learning for epitope discovery is to have a better understanding of the immune response--these features of the model have their place across the spectrum of precision medicine research.

Credit: 
Owkin, Inc.

How a cancer drug carrier's structure can help selectively target cancer cells

The main culprit in cancer is healthy cells that have gone rogue and acquire the ability to divide uncontrollably. These cells acquire growth advantages over normal cells and manipulate their environment by altering the cellular pathways involved in growth and metabolism. Over the past few decades, various altered pathways and proteins have been identified as targets for therapeutic interventions. However, what remains challenging is selectively targeting cancer cells and ensuring that the drug reaches the tumor in adequate amounts, without severely affecting normal cells. And in this regard, biocompatible delivery vehicles (which are non-toxic to normal cells) can be useful.

One such potential candidate is "porphyrins," a group of organic cyclic compounds that form the functional center of several proteins in the human body. Porphyrins are known for their "photosensitizing" effects, that is, their ability to release reactive oxygen species upon light stimulation. These reactive species are what gives porphyrins their anticancer activity. Porphyrins have another advantage: structurally, they are composed of four subunits called "pyrrole subunits," which give them specific electronic properties. These electronic properties, in combination with receptors on cancer cells, facilitate the selective accumulation of porphyrins in cancer cells, thereby serving as an effective drug delivery system. But how the steric position (atomic arrangement) of the functional groups bound to porphyrins favors maximum accumulation and distribution of porphyrin-conjugated drugs in cancer cells hasn't been well studied.

To answer this question, researchers at Tokyo University of Science, including Asst. Prof. Toshifumi Tojo, Mr. Koshi Nishida, Assoc. Prof. Takeshi Kondo, and Prof. Makoto Yuasa, dug deeper into how the structure of porphyrin derivatives can affect tumor accumulation. Their findings are published in the journal Scientific Reports. Explaining their motivation, Dr. Tojo, who led the study, says, "Porphyrins are used as the basic skeleton of new drugs for cancer treatment due to their ability to accumulate in cancer cells. They possess different functional group modification positions for drug conjugation. Whether these positions confer different physical properties and membrane permeability remains unclear. Our aim was to investigate how these differences impact drug delivery."

In their study, the researchers explored the β (third) and meso (middle) position of functional groups in porphyrins. First, using a breast cancer cell line, they looked into how these functional positions affect the time-dependent accumulation in cancer cells, ranging from 2- to 24-hour time points. They found that meso-derivatives accumulated in cells at 3-fold higher amounts than β-derivatives and that derivatives with smaller functional groups allowed better aggregation than the larger ones.

Next, they investigated how these functional group positions influence the pathway by which porphyrins enter cancer calls. They found that porphyrin conjugates form complexes with plasma proteins that facilitate their transport via endocytic vesicles. Additionally, the compounds could also diffuse into the cytoplasm through the cell membrane.

Moreover, considering their electron-rich nature, porphyrins likely interact with serum proteins that transport them to the cells. The researchers, therefore, measured how different positions influence the affinity of these porphyrin conjugates with serum proteins and how increased affinity may enhance tumor accumulation. They found that while the meso-position improves intracellular accumulation of porphyrin conjugates, it did not have a major effect on the movement of small functional groups into the cell.

Concluding their findings, Dr. Tojo remarks, "Our study reveals that the functional group modification position of porphyrin greatly affects the membrane permeability and intra-cellular tumor accumulation. We are hopeful that our findings can help inform guidelines for the structural design of novel porphyrin drugs."

Overall, their study gives insight into how the structure of drug delivery systems like porphyrins must be considered to achieve maximum efficacy, hopefully paving the way for advancements in cancer drug delivery.

Credit: 
Tokyo University of Science

Heparin targets coronavirus spike protein, research shows

image: Molecular modelling of interactions of heparin saccharides (coloured stick and balls) with the receptor binding domain of the Spike protein of SARS-CoV2 virus (yellow/green ribbon), which interfere with its binding to the ACE2 receptor on human cells.

Image: 
Mycroft-West et al.

An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus' ability to attach to human cells and infect them.

The research, published in the journals British Journal of Pharmacology, and Thrombosis and Haemostasis, found that heparin interacts with the spike protein on the surface of coronavirus (SARS-CoV2), destabilising its structure and preventing it from docking with the ACE2 receptor on human cells.

Molecular modelling by collaborators at Queensland University in Australia showed how heparin can stick to the surface of the spike protein to achieve these effects, and studies with live SARS-CoV2 virus carried out at Public Health England's Porton Down laboratory showed that unfractionated heparin (but not low molecular weight heparins) could inhibit cell infectivity at doses similar to those currently used in clinical settings as an anticoagulant.

Crucially, the data strongly supported the clinical testing of inhaled ("nebulised") unfractionated heparin, since the doses known to be delivered to the lungs would have very strong anti-viral effects.

Professor Jeremy Turnbull from the Department of Biochemistry and Systems Biology at the University of Liverpool said: "This is exciting news since heparin could be rapidly repurposed to help alleviate Covid-19 infections, or possibly as a prophylactic treatment for high-risk groups such as medical staff or care workers. The results have also led us to investigate other novel compounds which mimic heparin that could potentially be effective against SARS-CoV2."

Dr Mark Skidmore from the School of Life Sciences at Keele University co-led the research. He said: "We also know that heparins inhibit a range of other viruses, so studying these drugs could provide new therapeutic strategies, and possibly a first-line of defence against emerging viral threats in the future, for example while vaccines are developed."

Professor Miles Carroll, of the National Infection Service, Public Health England added: "New treatments which target the SARS-CoV2 virus are urgently needed. Heparin, with its well-known clinical safety profile, is certainly an interesting candidate for repurposing against Covid-19."

"The Covid-19 pandemic has had a significant impact on the delivery of NHS services and local communities. These results strengthen the need for further investigation of heparin as a treatment in Covid-19 patients," said Dr Quentin Nunes, Consultant at the East Lancashire Hospitals NHS Trust, who is leading efforts to begin clinical trial of nebulised heparin in ITU patients in the UK.

The early release of preprint data from this study in March 2020, now published in peer-reviewed journals, has stimulated international efforts to explore the use of heparins for Covid-19 treatment. Further work is now ongoing to explore the potential of heparin and heparin-mimicking compounds as potential broad-spectrum antiviral drugs for Covid-19 and other emerging viral threats.

Credit: 
University of Liverpool

Livestock workers face high MRSA risk

EAST LANSING, Mich. - For Michigan State University's Felicia Wu, the surprise isn't that people who work with livestock are at higher risk of picking up antibiotic-resistant bacteria, but instead how much higher their risk levels are.

"This is a bit of a wakeup call," said Wu, John. A Hannah Distinguished Professor in the Departments of Food Science and Human Nutrition and Agricultural, Food and Resource Economics. "I don't think there was much awareness that swine workers are at such high risk, for example. Or that large animal vets are also at extremely high risk."

Compared with individuals who don't work with animals, those working on swine farms are more than 15 times more likely to harbor a particular strain of a bacterium known as methicillin-resistant Staphylococcus aureus, or MRSA, acquired from livestock. For cattle workers, that number is nearly 12. For livestock veterinarians, it approaches eight.

Wu and Chen Chen, a research assistant professor in the Department of Food Science and Human Nutrition, published their findings, along with the risk factors for other related professions, in the journal Occupational & Environmental Medicine. Their paper highlights these elevated risks, what farmers can do to protect themselves and what we understand about the public health burden posed by livestock-associated MRSA.

"Livestock-associated MRSA is a strain of MRSA that is especially infectious among animals. Now it has evolved to infect humans as well," said Wu, who was recently named a fellow of the Society for Risk Analysis. "Bacteria have shown an amazing ability to jump across species to colonize and cause infections."

Livestock-associated MRSA is a zoonotic disease, a disease that can transmit between animals and humans. Such diseases can have devastating consequences for human health. The novel coronavirus pandemic, for example, was caused by a virus that likely originated in bats.

Although the novel coronavirus and livestock-associated MRSA work and spread in different ways, they both are a reminder that when people understand the risks posed by such diseases, they do have some power to minimize them. For example, good hygienic practices and policies supported by science can make meaningful differences, especially in the case of livestock-acquired MRSA, Wu said.

"The final message is that we need to protect our health and the health of our animals," she said. "We don't have control over bats, but we do have some level of control over how we raise and handle our poultry, cattle and swine."

Although it's possible to carry MRSA without it becoming a problem, the bacteria can cause serious infections when given the chance. Livestock-associated MRSA was first documented in the early 2000s and appears to be less dangerous to humans than MRSA that evolved in health care settings, where it built up defenses against a range of antibiotics.

The livestock-associated strain also appears to be less prevalent than community-associated MRSA, caused by bacteria lurking in gyms, schools and workplaces, which are typically more treatable than their counterparts found in hospitals and doctors' offices.

For these reasons, livestock-associated MRSA doesn't garner as much attention as other strains, but there's still much to learn about the bacteria from livestock and their impact on human health, Wu said. When she first came to MSU in 2013, she became interested in how the growing problem of antibiotic resistance was being influenced by bacteria that jumped to humans from livestock.

"We don't understand how much of that problem we have in human populations," said Wu. "This particular paper is trying understand one aspect of that."

To calculate the risk levels of acquiring livestock-associated MRSA, Wu and Chen combed through 15 years of published literature, extracting data about the likelihood of people acquiring the bacteria based on their livestock-related profession. The risk was elevated for every occupation they studied: vets, slaughterhouse employees and people who worked with swine, horses, cattle and poultry.

But there is also positive news to share along with the unsettling risk numbers. In 2017, the U.S. Food and Drug Administration introduced rules and monitoring programs to curb the use of antibiotics. Farmers can still use antibiotics to treat and prevent disease, but the agency forbid the use of antibiotics to spur animal growth. This has reduced the pressure on bacteria in agriculture settings to evolve resistance to antibiotics.

There are also a number of straightforward precautions individuals can take to help protect themselves and their animals. MRSA lives on soft tissue -- on people's skin and in their noses -- and can do so without causing harm when that tissue is intact. Reducing exposure of broken skin to the environment by keeping cuts and open wounds clean and covered can help reduce the risk of infection. Other simple steps, like regular hand-washing along with wearing gloves and protective clothing, can also stem the spread of livestock-acquired MRSA.

"Once the bacteria get a hold in an environment, they are really, really hard to get rid of," said Wu. "Reducing the risk of antibiotic-resistant infections is one of the main goals that farmers have"

Credit: 
Michigan State University

Drugs used to treat HIV and flu can have detrimental impact on crops

The increased global use of antiviral and antiretroviral medication could have a detrimental impact on crops and potentially heighten resistance to their effects, new research has suggested.

Scientists from the UK and Kenya found that lettuce plants exposed to a higher concentration of four commonly-used drugs could be more than a third smaller in biomass than those grown in a drug-free environment.

They also examined how the chemicals transferred throughout the crop and found that, in some cases, concentrations were as strong in the leaves as they were in the roots.

The study - published in Science of the Total Environment - was conducted by environmental chemists from the University of Plymouth (UK), Kisii University (Kenya) and Jomo Kenyatta University of Agriculture and Technology (Kenya).

It is one of the first worldwide to examine the impact of pharmaceutical compounds on agriculture, and to consider the subsequent risks for consumers.

For it, scientists focused on the drugs nevirapine, lamivudine and efavirenz - which are used to treat and prevent HIV/AIDS - and oseltamivir, which stops the spread of the flu virus in the body.

However, they say it is also relevant in light of the current COVID-19 pandemic, with antiviral medications having been approved for use to treat those affected by the virus.

Such compounds get into soils when they are irrigated with contaminated surface water, treated or untreated waste water, sewage sludge and biosolids.

Through a series of analyses, they showed there were differing levels of uptake across the four drugs with lamivudine exhibiting the lowest bioaccumulation - a level similar to that shown previously with caffeine.

However, when exposed to a combination of the four drugs (as would be found in the wider environment) mean leaf and root mass was reduced by 34%.

Preston Akenga, PhD researcher and the study's lead author, said: "The occurrence of pharmaceutical compounds in the environment is well documented. While the environmental levels measured may not pose a direct threat to human health, evidence of ecological effects in both aquatic and terrestrial systems demonstrates an environmental impact that could be significant if left unchecked."

The research team has previously suggested that failure to ensure the environmental sustainability of growing patient access to medicines in developing economies could increase the risk of adverse environmental impacts.

They also published research highlighting that the increased use of antibiotics in people with COVID-19 could be placing an additional burden on waste water treatment works and resulting in increased resistance to the drugs' benefits among the wider population.

Mark Fitzsimons, Professor of Environment Chemistry and a co-author on the research, said: "The successful trialling of antiviral drugs in the treatment of COVID-19 is positive for human health outcomes, but may result in significant additional input of pharmaceutical compounds to the environment leading to unintended ecological consequences."

Sean Comber, Professor of Environment Chemistry and the senior author on the research, added: "We hope this is the start of taking the fate and behaviour of antibiotic and antiviral drugs in the environment seriously. We can therefore link the prescription and the consequences for the benefit of both the patient and the ecosystem as a whole."

Credit: 
University of Plymouth

Study details N439K variant of SARS-CoV-2

An international team of researchers has characterized the effect and molecular mechanisms of an amino acid change in the SARS-CoV-2 Spike protein N439K. Viruses with this mutation are both common and rapidly spreading around the globe. The peer reviewed version of the study appears January 25 in the journal Cell.

Investigators found that viruses carrying this mutation are similar to the wild-type virus in their virulence and ability to spread but can bind to the human angiotensin converting enzyme 2 (ACE2) receptor more strongly. Importantly, researchers show that this mutation confers resistance to some individual's serum antibodies and against many neutralizing monoclonal antibodies, including one that is part of a treatment authorized for emergency use by the U.S. Food and Drug Administration.

"This means that the virus has many ways to alter the immunodominant domain to evade immunity while retaining the ability to infect and cause disease," says senior author Gyorgy Snell, Senior Director of Structural Biology at Vir Biotechnology. "A significant finding from this paper is the extent of variability found in the immunodominant receptor binding motif (RBM) on the spike protein."

Although the recently emerged UK variant, B.1.1.7, and the South African variant, B.1.351, have garnered more attention to date, the N439K mutation is the second most common in the receptor binding domain (RBD). The N439K mutation was first detected in Scotland in March 2020 and since then, a second lineage (B.1.258) has independently emerged in other European countries, which, by January 2021, was detected in more than 30 countries across the globe.

The Cell study also reports the X-ray crystal structure of the N439K RBD. "Our structural analysis demonstrates that this new mutation introduces an additional interaction between the virus and the ACE2 receptor," Snell says. "A single amino acid change (asparagine to lysine) enables the formation of a new point of contact with the ACE2 receptor, in line with the measured two-fold increase in binding affinity. Therefore, the mutation both improves interaction with the viral receptor ACE2 and evades antibody-mediated immunity."

Once researchers determined that the N439K mutation did not change virus replication, they studied whether it allowed evasion of antibody-mediated immunity by analyzing the binding of more than 440 polyclonal sera samples and more than 140 monoclonal antibodies from recovered patients. They found that binding of a proportion of both monoclonal antibodies and serum samples were significantly diminished by N439K. Importantly, the N439K mutation allowed pseudoviruses to resist neutralization by a monoclonal antibody that has been approved by the FDA for emergency use as part of a two-antibody cocktail. One way around this problem, researchers say, could be the use of antibodies that target highly conserved sites on the RBD. "The virus is evolving on multiple fronts to try to evade the antibody response," Snell says.

He notes that one of the challenges in studying SARS-CoV-2 variants is the limited amount of sequencing that's currently being done overall: more than 90 million cases of COVID-19 have been recorded and only about 350,000 virus variants have been sequenced. "That's only 0.4%--just the tip of the iceberg," he says. "This underscores the need for broad surveillance, a detailed understanding of the molecular mechanisms of the mutations, and for the development of therapies with a high barrier to resistance against variants circulating today and those that will emerge in the future."

Credit: 
Cell Press

New IOF position paper urges routine use of DXA-VFA in fracture liaison services

A new position paper by an International Osteoporosis Foundation (IOF) Fracture Working Group reviews the clinical significance of vertebral fractures, and the rationale for performing vertebral fracture assessment (VFA) routinely within post-fracture care coordination programs such as fracture liaison services (FLS). [1]

VFA is a tool available on modern dual-energy X-ray absorptiometry (DXA) scanners which allows the detection of previous vertebral fractures by providing a lateral view of the spine during a regular DXA bone mineral density measurement of the hip and spine.

Professor Willem Lems, corresponding author of the position paper, stated:

"Vertebral fractures are independent risk factors for future vertebral and non-vertebral fractures. Yet the majority occur without the signs and symptoms of an acute fracture, and they often remain undetected. Routine use of VFA technology would allow fracture liaison services to detect more undiagnosed vertebral fractures and to identify, assess and monitor more high-risk patients in need of treatment."

With the availability of powerful anabolic therapies, which appear to act more rapidly than do anti-resorptives, IOF and ESCEO have set out recommendations for stratification of treatment according to baseline FRAX probability [2]. VFA detection of occult vertebral fractures in the FLS thus offers a valuable opportunity to further refine fracture risk assessment and to tailor treatment accordingly. Furthermore, awareness of baseline vertebral fractures facilitates definition of true new vertebral fracture events occurring during anti-osteoporosis treatment, and therefore enhances optimal monitoring and informs decisions to adjustment therapy if required.

FLS are important service models for delivering secondary fracture prevention for older adults presenting with a fragility fracture. The IOF Capture the Fracture® program's Best Practice Framework, the leading global initiative in support of secondary fracture prevention delivery through FLS, defines the essential and aspirational elements of service delivery for fracture care [3]. A questionnaire-based study of international FLSs based on the Best Practice Framework found that secondary fracture prevention is best delivered for hip fractures and remains suboptimal for vertebral fractures, where the care gap is clearly wider. [4].

Professor Nicholas Harvey, co-author and Chair of the IOF Committee of Scientific Advisors, noted:

"This position paper, the result of the close international collaboration between colleagues in the IOF Fracture Working Group and the MRC Lifecourse Epidemiology Unit, University of Southampton, documents the substantial potential for the improved detection of vertebral fractures within fracture liaison services. The findings are perfectly synergistic with recent guidelines from IOF and ESCEO which set out a personalised medicine approach to treatment based on level of fracture risk. VFA thus offers a useful tool in the FLS with which to further characterise risk and so select the most appropriate treatment for an individual patient."

Credit: 
International Osteoporosis Foundation

Scientists find key function of molecule in cells crucial for regulating immunity

CHAPEL HILL, NC - Many molecules in our bodies help our immune system keep us healthy without overreacting so much that our immune cells cause problems, such as autoimmune diseases. One molecule, called AIM2, is part of our innate immunity - a defense system established since birth - to fight pathogens and keep us healthy. But little was known about AIM2's contribution to T cell adaptive immunity - defenses developed in response to particular pathogens and health problems we develop over the course of our lives.

Now, UNC School of Medicine scientists led by Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics, and Yisong Wan, PhD, professor of microbiology and immunology, discovered that AIM2 is important for the proper function of regulatory T cells, or Treg cells, and plays a key role in mitigating autoimmune disease. Treg cells are a seminal population of adaptive immune cells that prevents an overzealous immune response, such as those that occurs in autoimmune diseases.

Published in Nature, the research shows that AIM2 is actually expressed at a much higher level in Treg cells of the adaptive immune system than in innate immune cells.

"Our study unveils an unexpected and previously unappreciated role for AIM2 in Treg cells in adaptive immunity, which is independent of AIM2's classic function in the innate immunity," said Ting, co-senior author of the study, member of the UNC Lineberger Comprehensive Cancer Center, and director of the Center for Translational Immunology.

Wan, co-senior author and member of the UNC Lineberger Comprehensive Cancer Center, added, "Because Treg cells are well-known players in a broad range of diseases including autoimmunity, inflammation, and cancers, our findings will help us identify new molecular targets and develop new therapeutic strategies to test against debilitating and fatal diseases."

Normal immune responses are carried out by both innate immunity and adaptive immunity to fight pathogens and maintain biological stability. But these responses need to be regulated so they do not escalate and cause a whole host of different health problems aside from what the pathogen originally caused. Distinct cell types and molecules play discrete roles in the down-regulation of innate immunity and adaptive immunity. This work shows that AIM2, in Treg cells, is one of them. Treg cells dampen over-exuberant immune responses, and so they are critical for the check-and-balance of the immunity system.

Impaired function of Treg cells often perturbs immune system stability and can trigger autoimmune and inflammatory diseases.

In lab experiments led by first author Wei-Chun Chou, PhD, research associate in the Ting Lab, the UNC scientists found that AIM2 was expressed at a much higher level in Treg cells than in innate immune cells, in both mice and humans.

"This suggests a big role for AIM2 in Treg cells," Chou said. "We found that AIM2 is important to maintain the normal function of Treg cells, which could not effectively protect mice from developing autoimmune encephalomyelitis and inflammatory colitis without AIM2."

Those two conditions are models of the human diseases multiple sclerosis and colitis.

"We conducted further molecular and biochemical analysis to reveal a new, cellular signaling pathway of protein molecules in Treg cells - called the AIM2-RACK1-PP2A-AKT pathway - which regulates the metabolism and function of Treg cells to mitigate autoimmune disease."

Credit: 
University of North Carolina Health Care

'Be a man': Why some men respond aggressively to threats to manhood

DURHAM, N.C. -- When their manhood is threatened, some men respond aggressively, but not all. New research from Duke University suggests who may be most triggered by such threats - younger men whose sense of masculinity depends heavily on other people's opinions.

"Our results suggest that the more social pressure a man feels to be masculine, the more aggressive he may be," said Adam Stanaland, a Ph.D. candidate in psychology and public policy at Duke and the study's lead author.

"When those men feel they are not living up to strict gender norms, they may feel the need to act aggressively to prove their manhood -- to 'be a man'."

The pair of studies considered 195 undergraduate students and a random pool of 391 men ages 18 to 56.

Study participants were asked a series of questions about "gender knowledge." For men, these included questions on such stereotypical topics such as sports, auto mechanics and home repair. After answering, participants were randomly told their score was either higher or lower than that of an average person of their gender.

To simulate real-world threats to manhood, men who received a low score were also told they were "less manly than the average man."

After receiving their quiz scores, study participants were asked to complete a series of word fragments by adding missing letters, in order to reveal their state of mind. The results were striking, revealing aggressive thoughts among certain men but not others.

Men whose sense of masculinity came from within seemed unruffled by receiving a low score. It was a different story for men with a more fragile sense of masculinity, whose feelings of masculinity relied on others. That group included men who said they behaved "like a man" due to social pressures such as the desire to fit in, be liked or get dates.

Men with a more fragile sense of masculinity responded to the word fragments by creating words with violent associations rather than neutral meanings. For instance, when provided with the letters "ki" and asked to complete the word, they wrote "kill" rather than, say, "kiss." When given the letters "blo," they typed "blood" instead of a word such as "blow" or "bloom."

Those aggressive responses were strongest among the youngest study participants, men between 18 and 29 years old. The response was milder among middle-aged men between ages 30 and 37, and milder still among the oldest group of participants, men ages 38 years old and older.

"It's clear that younger men are more sensitive to threats against their masculinity," Stanaland said.

"In those years, as men attempt to find or prove their place in society, their masculine identity may be more fragile. In many places, this means that younger men are hit constantly with threats to their manhood. They have to prove their manhood every day of their lives."

Female students did not display a similar aggressive response when their gender was threatened.

Men's aggressive responses didn't end with the study questionnaire, the researchers noted. The study designers received violent threats from some men who received low scores - further evidence that the study hit a nerve.

Stanaland said he hopes to delve further into the forces that shape men's aggression.

"Men report aggressive behavior in all sorts of domains," Stanaland said. "Some of them are trying to prove their own manhood by being aggressive.

"Men's violence, terrorism, violence against women, political aggression - fragile masculinity may explain many of these behaviors. It's in everyone's interest to understand this phenomenon better."

Credit: 
Duke University

Lasing mechanism found in water droplets

image: Water droplet contact angle dramatically increases lasing emissions, from Qiao et al., doi 10.1117/1.AP.3.1.016003.

Image: 
Qiao et al.

Tiny molecular forces at the surface of water droplets can play a big role in laser output emissions. As the most fundamental matrix of life, water drives numerous essential biological activities, through interactions with biomolecules and organisms. Studying the mechanical effects of water-involved interactions contributes to the understanding of biochemical processes. According to Yu-Cheng Chen, professor of electronic engineering at Nanyang Technological University (NTU), "As water interacts with a surface, the hydrophobicity at the bio-interface mainly determines the mechanical equilibrium of the water. Molecular hydrophobicity at the interface can serve as the basis for monitoring subtle biomolecular interactions and dynamics."

Water droplets have been used to form biological microlasers that exploit water's intrinsic ability to confine light with minimal scattering. Droplet lasers benefit from laser oscillation in a microcavity, so any subtle changes induced by the gain medium or cavity can be amplified, leading to dramatic changes of laser emission characteristics. While droplet lasers have become cutting-edge platforms in biochemical/physical studies and biomedical applications, the optical interaction between droplet resonators and an interface has remained unknown.

As reported in Advanced Photonics, Chen's NTU team recently discovered that when a water droplet interacts with a surface to form a contact angle, the interfacial molecular forces determine the geometry of a droplet resonator. Dramatic mechanical changes at the interface play a significant role in the optical oscillation of droplet resonators.

Chen's group discovered an oscillation mechanism of droplet resonators, in which the laser resonates along the droplet-air interface in the vertical plane. Chen notes that this vertically oriented "rainbow-like" or "arc-like" lasing mode reflects back and forth between the two ends of the droplet interface, forming a unique and extremely strong laser emission. Chen's team noticed that, unlike the commonly seen whispering-gallery mode (WGM), this newly discovered lasing mechanism is much more sensitive to interfacial molecular forces. According to Chen, "The lasing emissions of this arc-like mode increase dramatically with the increment of interfacial hydrophobicity, as well as droplet contact angle."

Seeking to explain this modulating phenomenon, Chen's team also found that the quality- factor of new lasing modes increased significantly with an increasing droplet contact angle. And the number of oscillation paths of lasing modes in droplets increased dramatically. "Together, these two factors determine the enhancement of lasing emissions with the strength of interfacial molecular forces," says Chen.

Based on their discovery, Chen's team explored the possibility of employing droplet lasers to record mechanical changes at biointerfaces. As anticipated, they found that a tiny change of interfacial biomolecular forces, induced by a very low concentration of biomolecules, such as peptides or proteins, can be recorded by the lasing emissions of droplet lasers.

According to Chen, "This work demonstrates an important modulating mechanism in droplet resonators and shows the potential for exploiting optical resonators to amplify the changes of intermolecular forces." Lasing mechanism insights open new prospects for using microlasers to study biomechanical interactions and interface physics. As droplet lasers may provide a new platform for studying the intermolecular physical interactions at the interface, they could be particularly useful for examining hydrophobic interactions, which play a vital role in numerous physical dynamics and biological systems.

Credit: 
SPIE--International Society for Optics and Photonics